[Experience with CS-1170 in gynecological infections (author's transl)]. 1979

I Matsuoka, and K Shirakawa

CS-1170 was used in gynecological cases of infection, and the following satisfactory results were obtained. 1. The drug was markedly effective in 3 of 12 cases, effective in 7, and ineffective in 2, being the efficacy rate 83.3%. 2. It was highly effective even in the cases in which cefazolin (CEZ) and sulbenicillin (SBPC) were ineffective. 3. The results of the bacteriological examinations turned to negative in 7 cases, but continued to be positive in 2, being the bacteriological efficacy rate 77.7%. It is noteworthy that E. coli completely disappeared by the administration of CS-1170 in 2 cases in which CEZ was ineffective. 4. No side effect attributable to CS-1170 administration was observed.

UI MeSH Term Description Entries
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D002511 Cephalosporins A group of broad-spectrum antibiotics first isolated from the Mediterranean fungus ACREMONIUM. They contain the beta-lactam moiety thia-azabicyclo-octenecarboxylic acid also called 7-aminocephalosporanic acid. Antibiotics, Cephalosporin,Cephalosporanic Acid,Cephalosporin,Cephalosporin Antibiotic,Cephalosporanic Acids,Acid, Cephalosporanic,Acids, Cephalosporanic,Antibiotic, Cephalosporin,Cephalosporin Antibiotics
D002513 Cephamycins Naturally occurring family of beta-lactam cephalosporin-type antibiotics having a 7-methoxy group and possessing marked resistance to the action of beta-lactamases from gram-positive and gram-negative organisms. Antibiotics, Cephamycin,Cephamycin,Cephamycin Antibiotics
D004341 Drug Evaluation Any process by which toxicity, metabolism, absorption, elimination, preferred route of administration, safe dosage range, etc., for a drug or group of drugs is determined through clinical assessment in humans or veterinary animals. Evaluation Studies, Drug,Drug Evaluation Studies,Drug Evaluation Study,Drug Evaluations,Evaluation Study, Drug,Evaluation, Drug,Evaluations, Drug,Studies, Drug Evaluation,Study, Drug Evaluation
D005260 Female Females
D005831 Genital Diseases, Female Pathological processes involving the female reproductive tract (GENITALIA, FEMALE). Gynecologic Diseases,Female Genital Diseases,Diseases, Female Genital,Diseases, Gynecologic,Female Genital Disease,Genital Disease, Female,Gynecologic Disease
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D001424 Bacterial Infections Infections by bacteria, general or unspecified. Bacterial Disease,Bacterial Infection,Infection, Bacterial,Infections, Bacterial,Bacterial Diseases

Related Publications

I Matsuoka, and K Shirakawa
January 1979, The Japanese journal of antibiotics,
I Matsuoka, and K Shirakawa
January 1979, The Japanese journal of antibiotics,
I Matsuoka, and K Shirakawa
January 1979, The Japanese journal of antibiotics,
I Matsuoka, and K Shirakawa
February 1979, Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases,
I Matsuoka, and K Shirakawa
March 1979, The Japanese journal of antibiotics,
I Matsuoka, and K Shirakawa
August 1980, The Japanese journal of antibiotics,
I Matsuoka, and K Shirakawa
March 1979, The Japanese journal of antibiotics,
I Matsuoka, and K Shirakawa
February 1979, The Japanese journal of antibiotics,
I Matsuoka, and K Shirakawa
February 1979, The Japanese journal of antibiotics,
Copied contents to your clipboard!